Clinical Trial Update: Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS [NA]

View source ↗

Summary

Extension study evaluating the NTX100 neuromodulation system for medication-refractory primary Restless Legs Syndrome has completed, with results posted on 2024…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• NTX100 Neuromodulation System

Snippet

Sponsor: Noctrix Health, Inc. | Conditions: Restless Legs Syndrome | NA | Status: COMPLETED | Results posted: 2024-09-19